Merck & Co., Inc. (NYSE:MRK) Shares Sold by Fulton Bank N.A.

Share on StockTwits

Fulton Bank N.A. trimmed its holdings in Merck & Co., Inc. (NYSE:MRK) by 10.3% in the first quarter, Holdings Channel reports. The institutional investor owned 40,758 shares of the company’s stock after selling 4,664 shares during the quarter. Fulton Bank N.A.’s holdings in Merck & Co., Inc. were worth $3,390,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. PRW Wealth Management LLC bought a new position in shares of Merck & Co., Inc. in the fourth quarter valued at about $41,000. Aspire Private Capital LLC bought a new position in shares of Merck & Co., Inc. in the fourth quarter valued at about $55,000. Financial Gravity Companies Inc. bought a new position in shares of Merck & Co., Inc. in the fourth quarter valued at about $66,000. Mark Sheptoff Financial Planning LLC raised its holdings in shares of Merck & Co., Inc. by 150.0% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 1,000 shares of the company’s stock valued at $76,000 after buying an additional 600 shares during the last quarter. Finally, Vestor Capital LLC bought a new position in shares of Merck & Co., Inc. in the fourth quarter valued at about $77,000. 75.17% of the stock is owned by institutional investors and hedge funds.

A number of research firms recently issued reports on MRK. Goldman Sachs Group initiated coverage on Merck & Co., Inc. in a report on Tuesday, May 28th. They issued a “neutral” rating and a $85.00 price target for the company. Bank of America boosted their price objective on Merck & Co., Inc. from $90.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. BMO Capital Markets reissued a “hold” rating on shares of Merck & Co., Inc. in a report on Tuesday, February 19th. Argus boosted their price objective on Merck & Co., Inc. to $95.00 and gave the stock a “buy” rating in a report on Wednesday, February 20th. Finally, ValuEngine raised Merck & Co., Inc. from a “hold” rating to a “buy” rating in a report on Friday, May 3rd. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $83.08.

In other news, EVP Frank Clyburn sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $77.73, for a total transaction of $1,943,250.00. Following the completion of the transaction, the executive vice president now directly owns 92,604 shares in the company, valued at approximately $7,198,108.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert M. Davis sold 192,572 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $82.38, for a total value of $15,864,081.36. Following the transaction, the executive vice president now owns 330,232 shares of the company’s stock, valued at $27,204,512.16. The disclosure for this sale can be found here. Insiders have sold a total of 445,308 shares of company stock valued at $36,421,320 over the last 90 days. Corporate insiders own 0.27% of the company’s stock.

Shares of NYSE:MRK opened at $82.90 on Friday. The stock has a market cap of $213.64 billion, a price-to-earnings ratio of 19.10, a PEG ratio of 1.97 and a beta of 0.55. Merck & Co., Inc. has a 1-year low of $59.80 and a 1-year high of $84.27. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.37 and a quick ratio of 1.06.

Merck & Co., Inc. (NYSE:MRK) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.22 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.17. The firm had revenue of $10.82 billion during the quarter, compared to analysts’ expectations of $10.45 billion. Merck & Co., Inc. had a return on equity of 39.85% and a net margin of 19.50%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.05 EPS. As a group, sell-side analysts expect that Merck & Co., Inc. will post 4.72 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, July 8th. Stockholders of record on Monday, June 17th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.20 annualized dividend and a dividend yield of 2.65%. Merck & Co., Inc.’s payout ratio is currently 50.69%.

TRADEMARK VIOLATION WARNING: “Merck & Co., Inc. (NYSE:MRK) Shares Sold by Fulton Bank N.A.” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/4370961/merck-co-inc-nysemrk-shares-sold-by-fulton-bank-n-a.html.

Merck & Co., Inc. Company Profile

Merck & Co, Inc provides healthcare solutions worldwide. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases.

Further Reading: Beta

Want to see what other hedge funds are holding MRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck & Co., Inc. (NYSE:MRK).

Institutional Ownership by Quarter for Merck & Co., Inc. (NYSE:MRK)

Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Alliance Data Systems Co.  Receives Average Rating of “Hold” from Brokerages
Alliance Data Systems Co. Receives Average Rating of “Hold” from Brokerages
Host Hotels and Resorts Inc  Receives Consensus Recommendation of “Buy” from Analysts
Host Hotels and Resorts Inc Receives Consensus Recommendation of “Buy” from Analysts
Weir Group PLC  Given Consensus Rating of “Buy” by Analysts
Weir Group PLC Given Consensus Rating of “Buy” by Analysts
ViaSat, Inc.  Receives $96.99 Average Target Price from Analysts
ViaSat, Inc. Receives $96.99 Average Target Price from Analysts
Carrefour SA  Given Consensus Rating of “Hold” by Brokerages
Carrefour SA Given Consensus Rating of “Hold” by Brokerages
RTL Group S.A.  Receives €53.23 Consensus Target Price from Analysts
RTL Group S.A. Receives €53.23 Consensus Target Price from Analysts


© 2006-2019 Ticker Report